Works by Guglielmelli, Paola
Results: 129
Essential Thrombocythemia: A Review.
- Published in:
- JAMA: Journal of the American Medical Association, 2025, v. 333, n. 8, p. 701, doi. 10.1001/jama.2024.25349
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01176-7
- By:
- Publication type:
- Article
Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01052-4
- By:
- Publication type:
- Article
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00968-7
- By:
- Publication type:
- Article
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00786-x
- By:
- Publication type:
- Article
Breakthrough infections in MPN-COVID vaccinated patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00749-8
- By:
- Publication type:
- Article
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00743-0
- By:
- Publication type:
- Article
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00713-6
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00625-5
- By:
- Publication type:
- Article
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00581-6
- By:
- Publication type:
- Article
Mutations and thrombosis in essential thrombocythemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0289-2
- By:
- Publication type:
- Article
Clinical Phenotype and Genotype Correlations with Time to Progression into Post Polycythemia Vera and Post Essential Thrombocythemia Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S354, doi. 10.1016/j.clml.2017.07.183
- By:
- Publication type:
- Article
An International Multicenter Project on Secondary Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S91, doi. 10.1016/j.clml.2016.07.127
- By:
- Publication type:
- Article
Rationale for Targeting the PI3K/Akt/mTOR Pathway in Myeloproliferative Neoplasms.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Th e CXCR1/CXCR2 Inhibitor, Reparixin Reduces the Emperipolesis Between Neutrophils and Megakaryocytes in the Gata1<sup>low</sup> mice.
- Published in:
- Italian Journal of Anatomy & Embryology / Archivio Italiano di Anatomia Ed Embriologia, 2023, p. 160
- By:
- Publication type:
- Article
Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID‐19.
- Published in:
- International Journal of Laboratory Hematology, 2020, v. 42, n. 6, p. e270, doi. 10.1111/ijlh.13310
- By:
- Publication type:
- Article
Inconsistencies in the association between the JAK2<sup>V617F</sup> mutation and PRV-1 over-expression among the chronic myeloproliferative diseases.
- Published in:
- 2006
- By:
- Publication type:
- Letter
PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia.
- Published in:
- British Journal of Haematology, 2004, v. 127, n. 2, p. 214, doi. 10.1111/j.1365-2141.2004.05175.x
- By:
- Publication type:
- Article
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 7, p. 2299, doi. 10.1007/s00277-024-05665-4
- By:
- Publication type:
- Article
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 2, p. 141, doi. 10.1007/s00277-009-0788-5
- By:
- Publication type:
- Article
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46843-z
- By:
- Publication type:
- Article
Advances in Understanding and Management of Myeloproliferative Neoplasms.
- Published in:
- CA: A Cancer Journal for Clinicians, 2009, v. 59, n. 3, p. 171, doi. 10.3322/caac.20009
- By:
- Publication type:
- Article
Role of TGF‐β1/miR‐382‐5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2102, doi. 10.1002/1878-0261.12387
- By:
- Publication type:
- Article
CXCR4-independent rescue of the myeloproliferative defect of the gata1<sup>low</sup> myelofibrosis mouse model by Aplidin®.
- Published in:
- Journal of Cellular Physiology, 2010, v. 225, n. 2, p. 490, doi. 10.1002/jcp.22228
- By:
- Publication type:
- Article
Nano-GLADIATOR: real-time detection of copy number alterations from nanopore sequencing data.
- Published in:
- Bioinformatics, 2019, v. 35, n. 21, p. 4213, doi. 10.1093/bioinformatics/btz241
- By:
- Publication type:
- Article
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8166, doi. 10.1002/cam4.5618
- By:
- Publication type:
- Article
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 9, p. 4089, doi. 10.1002/cam4.2107
- By:
- Publication type:
- Article
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 8, p. 1962, doi. 10.3390/cells10081962
- By:
- Publication type:
- Article
CircRNAs Are Here to Stay: A Perspective on the MLL Recombinome.
- Published in:
- Frontiers in Genetics, 2019, p. N.PAG, doi. 10.3389/fgene.2019.00088
- By:
- Publication type:
- Article
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231205643
- By:
- Publication type:
- Article
Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10 9 /L to <100 × 10 9 /L) at baseline: the final analysis of EXPAND.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221118429
- By:
- Publication type:
- Article
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.
- Published in:
- Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 8a, p. 1437, doi. 10.1111/j.1582-4934.2009.00827.x
- By:
- Publication type:
- Article
Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 2, p. 279, doi. 10.1111/bjh.14764
- By:
- Publication type:
- Article
Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 938, doi. 10.1111/bjh.13644
- By:
- Publication type:
- Article
The ERCC2 Gln/ Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 3, p. 424, doi. 10.1111/bjh.12376
- By:
- Publication type:
- Article
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 446, doi. 10.1111/j.1365-2141.2010.08266.x
- By:
- Publication type:
- Article
Anaemia characterises patients with myelofibrosis harbouring Mpl<sup> W515 L/ K</sup> mutation.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 244, doi. 10.1111/j.1365-2141.2007.06565.x
- By:
- Publication type:
- Article
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 558, doi. 10.1002/hon.2898
- By:
- Publication type:
- Article
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature.
- Published in:
- Clinical & Experimental Medicine, 2020, v. 20, n. 2, p. 313, doi. 10.1007/s10238-020-00616-5
- By:
- Publication type:
- Article
δβ-Thalassemia and α-Triplication: Is Genetic Retesting Worthwhile in Case of Non-Coherent Phenotype?
- Published in:
- Hemoglobin, 2024, v. 48, n. 5, p. 349, doi. 10.1080/03630269.2024.2414109
- By:
- Publication type:
- Article